Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

Fri, 30th Nov 2018 07:38

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE 100 index is to open down 3.25 points at 7,035.70. The blue chip index closed up 34.43 points, or 0.5%, at 7,038.95 Thursday.In early UK corporate news, Babcock International group won a new contract in Canada and Bioquell agreed to be acquired by St Paul, Minnesota-headquartered firm Ecolab. FTSE 250-listed Babcock International said it won its first firefighting contract outside Europe. The contract from the government of Manitoba in Canada is worth around GBP100 million over ten years and will begin in April next year. The engineering services company said it will manage, maintain and operate Manitoba's fleet of seven firefighting fixed-wing Canadair water-bomber amphibious aircraft, supported by three of its own twin commander aircrafts. "This marks our first aviation emergency services contract in Canada, and we are delighted to be trusted to deliver this critical service. We have over 30 years' experience of aerial firefighting, and this new contract positions us well for any future opportunities in the North American market," said Chief Executive Archie Bethel. Biodecontamination products provider Bioquell said it has agreed to be acquired by US water, hygiene and energy technologies provider Ecolab for 590 pence in cash.The deal values Bioquell at around GBP140.5 million and the offer represents a 40% premium to Bioquell's closing share price of 420 pence on Thursday. Bioquell said its board has unanimously recommended Ecolab's offer to shareholders."As part of Ecolab, Bioquell will be able to drive faster strategic growth in both life sciences and healthcare markets leveraging Ecolab's extensive global footprint. The Bioquell Directors believe the strategic fit is extremely strong and that the combination offers employees and customers a highly desirable opportunity to continue Bioquell's successful tradition," said Bioquell Chairman Ian Johnson. Irish drugmaker Shire said it obtained European approval for its human monoclonal antibody Takhzyro intended for treatment of hereditary angioedema. Late Thursday, index provider FTSE Russell said Shire shares will be de-listed in London on January 2 due to its acquisition by Japan's Takeda Pharmaceutical. Later Friday, world leaders are set to open a two-day Group of 20 summit in Argentina, with global trade concerns expected to dominate, while the flare up in Russia-Ukraine tensions and the fallout from the murder of Saudi dissident Jamal Khashoggi are also likely to feature.While there have been some signs that Chinese and US delegations could reach a ceasefire on trade, there are growing worries that President Donald Trump and President Xi Jinping will not be able to make a breakthrough at their highly-anticipated meeting at the summit.Before departing Washington on Thursday, Trump said he was "very close" to reaching a deal with China but added: "I don't know that I want to do it because what we have right now is billions and billions of dollars coming into the US in the form of tariffs or taxes."The pound was flat, quoted at USD1.2778 from USD1.2780 at the London equities close Thursday.The pound remained under pressure after UK Prime Minister Theresa May on Thursday warned of a no-deal Brexit if parliament votes down her deal on December 11.The economic events calendar has Italy inflation and unemployment figures at 0900 GMT and 1000 respectively, and eurozone unemployment and inflation readings at 1000 GMT.In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.1%, S&P 500 down 0.2% and Nasdaq Composite ending 0.3% lower.Minutes from the Federal Reserve's monetary policy meeting held earlier this month are likely to reinforce expectations for another quarter-point increase in US interest rates next month.The minutes of the Federal Open Market Committee meeting said almost all participants agreed another increase in rates was "likely to be warranted fairly soon".The Fed noted a near-term rate hike would be dependent on incoming information on the labour market and inflation coming in line with or stronger than current expectations.In Asia, the Japanese Nikkei 225 index closed up 0.4%. In China, the Shanghai Composite closed up 0.7%, and the Hang Seng index in Hong Kong is up 0.6%.China's manufacturing activity continued to slow in November amid a prolonged trade war with the US, official data showed Friday.The manufacturing purchasing managers index came in at 50, compared to 50.2 in October, its worst result in more than two years. A figure above 50 indicates growth and one below 50 indicates contraction.The services PMI also slowed to 53.4 this month, down from 53.9 in October, the National Bureau of Statistics said.China's economy is feeling the effects of tariffs imposed earlier this year by the US, which accuses Beijing of unfair trade practices.

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.